You are here: Industry Insights > InventisBio

News List

InventisBio Announces $147 Million Series D Financing Led by Hillhouse Affiliate GL Ventures prnasia
October 10, 2020
InventisBio, a clinical stage biotech company dedicated to the research and development of innovative small molecule drugs, announced the recent completion of a $147 million series D financing which has attracted participation of ...
InventisBio closes $70M series C financing biospectrumasia
March 18, 2019
InventisBio Inc., a clinical stage biotech company, announced the closing of a $70 million USD Series C financing in January 2019. This round of investment was co-led by Advantech Capital and CMBI, followed by Pudong Innotek. Also participating were exist
Clinical Stage Biotech Company InventisBio Inc. Closes $70 Million USD Series C Financing en-cphi.cn
March 12, 2019
InventisBio Inc., a clinical stage biotech company, announced the closing of a $70 million USD Series C financing in January 2019.
InventisBio and Betta Pharma to Co-Develop Novel Drug for Non-Small Cell Lung Cancer pharmafocusasia
January 02, 2019
InventisBio (Shanghai) announced today that it has signed a "Collaboration Agreement" with Betta Pharma (hereinafter referred to as "Betta Pharma").....